EFSCE
TAK icon

Enterprise Financial Services Corp (EFSC)’s Takeda Pharmaceutical TAK Stock Holding History

Enterprise Financial Services Corp (EFSC)’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,178
Closed -$20K – 1119
2021
Q2 		$20K Buy
1,178
+168
+17% +$2.86K ﹤0.01% 588
2021
Q1 		$19K Buy
1,010
+176
+21% +$3.17K ﹤0.01% 606
2020
Q4 		$15K Sell
834
-58
-7% -$1.02K ﹤0.01% 630
2020
Q3 		$16K Sell
892
-29
-3% -$528 ﹤0.01% 602
2020
Q2 		$17K Buy
921
+512
+125% +$9.19K ﹤0.01% 584
2020
Q1 		$6K Sell
409
-538
-57% -$9.75K ﹤0.01% 773
2019
Q4 		$18K Buy
947
+430
+83% +$8.23K ﹤0.01% 603
2019
Q3 		$9K Buy
517
+202
+64% +$3.49K ﹤0.01% 733
2019
Q2 		$5K Sell
315
-245
-44% -$4.46K ﹤0.01% 903
2019
Q1 		$11K Buy
560
+550
+5,500% +$11.1K ﹤0.01% 732
2018
Q4 		$0 Buy
+10
New +$169 ﹤0.01% 1061

Other funds holding TAK

ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Glenview Capital Management
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Parametric Portfolio Associates
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Mondrian Investment Partners
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Enterprise Financial Services Corp (EFSC)'s TAK Position: Q3 2021 in Review

Enterprise Financial Services Corp (EFSC) sold out of Takeda Pharmaceutical (TAK) in Q3 2021, closing a stake of 1,178 shares — an estimated $20K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in TAK in Q4 2018 and held it in 11 quarters. The position peaked at $20K in Q2 2021. 293 funds tracked by Wall St. Rank hold TAK as of Q3 2021.

  • Enterprise Financial Services Corp (EFSC) reported no remaining Takeda Pharmaceutical position as of Q3 2021 after selling out during the quarter.
  • Enterprise Financial Services Corp (EFSC) sold 1,178 Takeda Pharmaceutical shares in Q3 2021, an estimated $20K.
  • Enterprise Financial Services Corp (EFSC) first reported a position in Takeda Pharmaceutical in Q4 2018 and held it in 11 quarters.
  • Enterprise Financial Services Corp (EFSC)'s Takeda Pharmaceutical position peaked at $20K in Q2 2021.
  • 293 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2021.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q3 2021, filed 15 Nov 2021.